Covid Vaccine Patent Waiver Is “No Silver Bullet”: European Council President


COVID-19: European Council President Charles Michel said that they want to focus on voluntary licenses, knowledge transfers and patent pooling.

Covid Vaccine Patent Waiver Is 'No Silver Bullet': European Council President

European Council President Charles Michel said patent waiver issue is likely to be raised at G7 summit.


A proposed waiver of intellectual property rights for COVID-19 vaccines and treatments is “no silver bullet”, European Council president Charles Michel said on Thursday, adding he expected the topic to feature at the G7 summit.

“The question of intellectual property rights will likely be raised,” Michel told a news conference ahead of the summit starting on Friday.

“The patent waiver might sound good, but it’s no silver bullet. The TRIPS agreement already offers flexibility and we want to focus on concrete proposals, such as promoting voluntary licences and knowledge transfers and patent-pooling on mutually agreed terms,” he continued.

(Except for the headline, this story has not been edited by our staff and is published from a syndicated feed.)


Please enter your comment!
Please enter your name here

All the data shown above will be stored by on At any point of time, you can contact us and select the data you wish to anonymise or delete so it cannot be linked to your email address any longer. When your data is anonymised or deleted, you will receive an email confirmation. We also use cookies and/or similar technologies to analyse customer behaviour, administer the website, track users' movements, and to collect information about users. This is done in order to personalise and enhance your experience with us. Click here to read our Cookie Policy.